{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:18:24Z","timestamp":1772137104330,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1053\/j.ajkd.2015.03.032","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T23:03:08Z","timestamp":1431730988000},"page":"450-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non\u2013Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)"],"prefix":"10.1053","volume":"66","author":[{"given":"Elise","family":"Schutte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiddo J.","family":"Lambers Heerspink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen L.","family":"Lutgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan J.L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Vart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.R.","family":"Wolffenbuttel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kausik","family":"Umanath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia B.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"de Zeeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 suppl 2","key":"10.1053\/j.ajkd.2015.03.032_bib1","first-page":"S12","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease","volume":"49","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2015.03.032_bib2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2015.03.032_bib3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2010.03.023","article-title":"Serum bicarbonate and long-term outcomes in CKD","volume":"56","author":"Menon","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2015.03.032_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","article-title":"Serum bicarbonate levels and the progression of kidney disease: a cohort study","volume":"54","author":"Shah","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2015.03.032_bib5","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","article-title":"Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD","volume":"24","author":"Kovesdy","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2015.03.032_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2215\/CJN.03730411","article-title":"Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease","volume":"6","author":"Navaneethan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.03.032_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MNH.0b013e32835dcbbe","article-title":"Does correction of metabolic acidosis slow chronic kidney disease progression?","volume":"22","author":"Goraya","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"10.1053\/j.ajkd.2015.03.032_bib8","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/ndt\/gfs291","article-title":"Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?","volume":"27","author":"Kovesdy","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2015.03.032_bib9","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.ajkd.2005.03.003","article-title":"Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment","volume":"45","author":"Kraut","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2015.03.032_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0272-6386(99)70422-1","article-title":"Metabolic acidosis in advanced renal failure: differences between diabetic and nondiabetic patients","volume":"33","author":"Caravaca","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2015.03.032_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2015.03.032_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2015.03.032_bib13","first-page":"155A","article-title":"MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine","volume":"11","author":"Levey","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2015.03.032_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/03637750903310360","article-title":"Beyond Baron and Kenny: statistical mediation analysis in the new millennium","volume":"76","author":"Hayes","year":"2009","journal-title":"Commun Monogr"},{"issue":"4","key":"10.1053\/j.ajkd.2015.03.032_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3758\/BF03206553","article-title":"SPSS and SAS procedures for estimating indirect effects in simple mediation models","volume":"36","author":"Preacher","year":"2004","journal-title":"Behav Res Methods Instrum Comput"},{"issue":"446","key":"10.1053\/j.ajkd.2015.03.032_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the\u00a0subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"1","key":"10.1053\/j.ajkd.2015.03.032_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ki.1980.14","article-title":"Hyperkalemia and hyporeninemic hypoaldosteronism","volume":"17","author":"DeFronzo","year":"1980","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2015.03.032_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0894-0959.2004.17606.x","article-title":"Poor nutritional status and inflammation: metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure","volume":"17","author":"Kalantar-Zadeh","year":"2004","journal-title":"Semin Dial"},{"issue":"3-4","key":"10.1053\/j.ajkd.2015.03.032_bib19","first-page":"189","article-title":"Delay in centrifugation and measurement of serum constituents in normal subjects","volume":"7","author":"Devgun","year":"1989","journal-title":"Clin Physiol Biochem"},{"issue":"1","key":"10.1053\/j.ajkd.2015.03.032_bib20","article-title":"2012 Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1053\/j.ajkd.2015.03.032_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000339329","article-title":"Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review","volume":"35","author":"Susantitaphong","year":"2012","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.03.032_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1681\/ASN.2014020205","article-title":"Current status of bicarbonate in CKD","volume":"26","author":"Dobre","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2015.03.032_bib23","unstructured":"Di Iorio B. Correction of metabolic acidosis in end stage renal disease (ESRD). 2012. http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01640119?term=NCT01640119&rank=1. Accessed March 6,\u00a02014."},{"key":"10.1053\/j.ajkd.2015.03.032_bib24","unstructured":"Melamed ML. Alkali therapy in chronic kidney disease. http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01452412?term=NCT01452412&rank=1. Accessed March 6,\u00a02014."},{"issue":"1","key":"10.1053\/j.ajkd.2015.03.032_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1745-6215-14-196","article-title":"Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)","volume":"14","author":"Gaggl","year":"2013","journal-title":"Trials"},{"key":"10.1053\/j.ajkd.2015.03.032_bib26","unstructured":"Raphael KL. Investigations of the optimum serum bicarbonate level in renal disease. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01574157?term=NCT01574157&rank=1. Accessed September 1,\u00a02014."}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615006253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615006253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:40:13Z","timestamp":1759459213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638615006253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0272638615006253"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.03.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725503819.793507757","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non\u2013Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}